Abiopharma

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

VYNE Therapeutics Updates for 12/15/2025

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

Class Action Filed Against Perrigo Company plc (PRGO) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm

Contact The Gross Law Firm by December 26, 2025 Deadline to Join Class Action Against DexCom, Inc.(DXCM)

Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Investors who lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class Action - BAX

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before January 5, 2026 to Discuss Your Rights - INSP

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm